Circulating plasma prekallikrein and tissue kallikrein in normotensive and hypertensive humans: Effects of angiotensin II infusion

Clinical and Experimental Hypertension

Volumn 20, Issue 3, 1998, Pages 313-328

  Ohman K P ^a   Karlberg, B E ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CHLORIDE; KININ; PLASMA KALLIKREIN; RENIN; SODIUM; TISSUE KALLIKREIN;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; KALLIKREIN KININ SYSTEM; MALE; RADIOIMMUNOASSAY; REAGIN TEST; URINARY EXCRETION;

EID: 0031924592     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969809052124     Document Type: Article

References (44)

1. Margolius HS. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease Hypertension 1995;26:221-229.
2. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
3. Roman RJ, Kaldunski ML, Scicli AG, Carretero OA. Influence of kinins and angiotensin II on papillary blood flow. Am J Physiol 1988;255 F690 - F698.
4. Nolly H, Scicli A, Scicli G, Carrtero O. Characterization of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ Res 1985;56:816-821.
5. Geiger R, Clausnitzer B, Fink E, Fritz H. Isolation of an enzymatically active glandular kallikrein from human plasma by immunoaffinity chromatography. Hoppe-Seyler's Z Physiol Chem 1980;361:1795-1803
6. Shimamoto K, Mayfield RK, Margolius HS, Chao J, Stroud W, Kaplan AP. Immunoreactive tissue kallikrein in human serum. J Lab Clin Med 1984;103:731-738.
7. Scicli AG, Ørstavik TB, Rabito SF, Murray RD, Carretero OA. Blood kinins after sympathetic nerve stimulation of the rat submandibular gland. Hypertension 1983;5:I-101 - I-106.
8. Erdös EG, Yang HYT. Kininases. In: Erdös EG, ed. Braykinin, kallidin and kallikrein. Berlin, Heidelberg, New York: Springer-Verlag, 1970: 289-323. (Eichler O, Farah A, Merken H, Welch AD, ed. Handbook of Experimental Pharmacology; vol 25).
9. Erdös EG, Yang HYT. Kininases. In: Erdös EG, ed. Braykinin, kallidin and kallikrein. Berlin, Heidelberg, New York: Springer-Verlag, 1970: 289-323. (Eichler O, Farah A, Merken H, Welch AD, ed. Handbook of Experimental Pharmacology; vol 25).
10. Pellacani A, Brunner HR, Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci 1994;87:567-574.
11. Öhman KP, Karlberg BE. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans. Clin Sci 1991;81:305-311.
12. Sealey JE, Atlas SA, Laragh JH. Linking the kallikrein and renin systems via activation of inactive renin. Am J Med 1978;65:994-1000.
13. Fyhrquist F, Soveri P, Puutula L, Stenman UH. Radioimmunoassay of plasma renin activity. Clin Chem 1976,22:250-256.
14. Kappelgaard AM, Damkjaer-Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 1976;67:299-306.
15. McKenzie JK, Clements JA. Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol 1974; 38:622-627.
16. Brown RD, Swander A, McKenzie JK. Urine aldosterone radioimmunoassay: validation of a method without chromatography. J Clin Endocrinol 1976;42:984-900.
17. Bagshaw AF, Bhoola KD, Lemon MJC, Whicher JT. Development and characterization of a radioimmunoassay to measure human tissue kallikrein in biological fluids. J Endocrinol 1984;101:173-179.
18. Friberger P, Eriksson E, Gustavsson S, Claesson G. Determination of prekallikrein in plasma by means of a chromogenic tripeptide substrate for plasma kalllikrein. In: Fujii S, Moriya H, Suzuki T, ed. Kinins II. Biochemistry, pathophysiology, and clinical aspects. New York & London: Plenum Publishing Corp, 1979: 67-82.
19. Amundsen E, Putter J, Friberger P, Knös M, Larsbraten M, Claeson G. Methods for determination of glandular kallikrein by means of chromogenic tripeptide substrate. In: Fujii S, Moriya H, Suzuki T, ed. Kinins II. Biochemistry, pathophysiology, and clinical aspects. New York & London: Plenum Publishing Corp, 1979: 83-95.
20. Aasen OA, Frolich W, Saugstad OD, Amundsen E. Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs. Eur Surg Res 1978;10:50-62.
21. Dela Cadena RA, Suffredini AF, Page JD, Pixley RA. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 1993;81:3313-3317.
22. Khan MM, Yamamoto T, Araki H, Shibuya Y, Kambara T. Role of Hageman factor/kallikrein-kinin system in pseudomonal elastase-induced shock model. Biochim Biophys Acta 1993;1157:119-126.
23. Hathaway WE, Wuepper KD, Weston WL, Humbert JR, Rivers RPA, Genton E, August CS, Montgomery RR, Mass MF. Clinical and physiological studies of two siblings with prekallikrein (Fletcher factor) deficiency. Am J Med 1976;60:654-664.
24. Saito H, Ratnoff OD, Waldmann R, Abraham JP. Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma endhancing vascular permeability (PF/DIL). J Clin Invest 1975;55:1082-1089.
25. Scicli AG, Mindroiu T, Scicli G, Carretero OA. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. J Lab Clin Med 1982;100:81-93.
26. Hollenberg NK, Chenitz WR, Adams DF, Williams GH. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 1974;54:34-42.
27. Kaplan NM, Silah JG. The effect of angiotensin II on the blood pressure in humans with hypertensive disease. J Clin Invest 1964;43:659-669.
28. Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AD. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 1981;52:195-198.
29. Marks AD, Marks DB, Kim YN, Moctezuma J, Adlin EV, Channik BJ. The pressor response to angiotensin II in patients with low renin essential hypertension. Circ Res 1978;42;864-869.
30. Tomita K, Endou H, Sakai F. Localization of kallikrein-like activity along a single nephron in rabbits. Pflügers Arch 1981;389:91-95.
31. Nishimura K, Shimizu H, Kokubu T. Existence of prokallikrein in the kidney. Its biochemical properties compared to three active glandular kallkreins from the kidney, serum, and urine of the rat. Hypertension 1983;5:205-210.
32. Hial V, Keiser HR, Pisano JJ. Origin and content of methionyl-lysyl-bradykinin, lysyl-bradykinin, and bradykinin in human urine. Biochem Pharmacol 1976;25:2499-2503.
33. Marks ES, Frech MA, Proud D, Keiser HR. Effect of alterations in extracellular fluid volume on urinary kallikrein in the conscious rat. Hypertension 1982;4:625-633.
34. Margolius HS, Geller R, Pisano JJ, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet 1971;ii:1063-1065.
35. Schiffrin EL, Gutkowska J, Julesz J, Thibault G, Genest J. Effect of low normal and high normal sodium intake on hormonal and metabolic responses to ACTH, antiotensin II an dan acute salt load in normal subjects. Clin Invest Med 1984;7:149-155.
36. Macfarlane NAA, Adetuyibi A, Mills IH. Changes in kallikrein excretion during arterial infusion of angiotensin. J Endocrinol 1974;61:xxii.
37. Mills IH, Lee G, Brownlee AA. Urinary kallikrein in the rat: stimulation with angiotensin infusion but depression with increasing sodium concentration. J Physiol 1994;481.2:425-437.
38. Rabito S, Scicli A, Carretero O. Immunoreactive glandular kallikrein in plasma during alterations of urinary kallikrein excretion. Hypertension 1983;5:V-153 - V-157.
39. Margolius HS, Horwitz D, Geller RG, Alexander RW, Gill JR, Pisano JJ, Keiser HR. Urinary kallikrein excretion in normal man. Relationship to sodium intake and sodium-retaining steroids. Circ Res 1974;35:812-819.
40. Margolius HS, Horwitz D, Pisano JJ, Keiser HR. Urinary kallikrein excretion in hypertensive man. Relationship to sodium intake and sodium-retaining steroids. Circ Res 1974;35:820-825.
41. Margolius HR, Chao J. Amiloride inhibits mammalian renal kallikrein and a kallikrein-like enzyme from toad bladder and skin. J Clin Invest 1980;65:1343-1350.
42. Mizelle HL, Montani J-P, Hester RL, Didlake RH, Hall JE. Role of pressure natriuresis in long-term control of renal electrolyte excretion. Hypertension 1993;22;102-110.
43. Blantz RC. The glomerular and tubular actions of angiotensin II. Amer J Kidney Dis 1987;X:2-6.
44. Cogan MG. Angiotensin II: A powerful controller of sodium transport in the early proximal tubule. Hypertension 1990;15:451-458.